Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

Australia

Austria

Belgium

Brazil *

Canada

China *

Denmark

Finland

France

Germany

Hong Kong (China) *

India *

Ireland

Italy

Japan *

Luxembourg

Mexico *

Netherlands

Norway

Philippines *

Republic of Korea *

Singapore *

Spain

Sweden

Switzerland

Thailand *

United Kingdom

United States

AlphaLISA SureFire Ultra Human Total HIF-1α Detection Kit, 100 Assay Points

The AlphaLISA™ SureFire® Ultra™ Human Total HIF2α assay is a sandwich immunoassay for quantitative detection of total HIF2α in cellular lysates using Alpha Technology.

View product information

Feature	Specification
Application	細胞シグナル伝達
Protocol Time	2h at RT
Sample Volume	30 µL

The AlphaLISA™ SureFire® Ultra™ Human Total HIF2α assay is a sandwich immunoassay for quantitative detection of total HIF2α in cellular lysates using Alpha Technology.

View product information

Product variants

Unit Size: 100 Assay Points

Part #:

ALSU-THIF-A-HV

Unit Size: 500 Assay Points

Part #:

ALSU-THIF-A500

Unit Size: 10,000 Assay Points

Part #:

ALSU-THIF-A10K

Unit Size: 50,000 Assay Points

Part #:

ALSU-THIF-A50K

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Request more information

Product information

Overview

Hypoxia-Inducible Factor 2-Alpha (HIF2α) is an oxygen-sensitive transcription factor that regulates cellular adaptation to hypoxia by controlling genes involved in angiogenesis, erythropoiesis, and metabolism. Under normoxic conditions, HIF2α is hydroxylated by prolyl hydroxylases, leading to VHL-mediated degradation. During hypoxia, HIF2α stabilizes and heterodimerizes with HIF1β to bind hypoxia response elements in target gene promoters. HIF2α uniquely regulates erythropoietin, VEGF in endothelial cells, and genes involved in lipid metabolism. Mutations in VHL or HIF2α cause polycythemia and clear cell renal cell carcinoma, where constitutive HIF2α activity drives tumor growth. HIF2α-specific inhibitors such as belzutifan have shown remarkable efficacy in ccRCC.

The AlphaLISA SureFire Ultra Human Total HIF2α is a sandwich immunoassay for the quantitative detection of total HIF2α in cellular lysates, using Alpha Technology.

Formats:

The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.
The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.
The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.
The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.

AlphaLISA SureFire Ultra kits are compatible with:

Cell and tissue lysates
Antibody modulators
Biotherapeutic antibodies

AlphaLISA SureFire Ultra kits can be used for:

Cellular kinase assays
Receptor activation studies
High-throughput screening for preclinical studies

How it works

Total-AlphaLISA SureFire Ultra assay principle

The Total-AlphaLISA SureFire Ultra assay measures the expression level of a protein target in a cell lysate.

The Total-AlphaLISA SureFire Ultra assay uses two antibodies which recognize two different distal epitopes on the targeted protein. AlphaLISA assays require two bead types: Acceptor and Donor beads. Acceptor beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor beads are coated with streptavidin to capture one of the detection antibodies, which is biotinylated. In the presence of targeted protein, the two antibodies bring the Donor and Acceptor beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor bead, allowing the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.

Total-AlphaLISA SureFire Ultra two-plate assay protocol

The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Ultra detection reagents. This protocol permits the cells viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.

2 plates assay protocol AlphaLISA Surefire Ultra Total assay

Total-AlphaLISA SureFire Ultra one-plate assay protocol

Detection of Total target protein with AlphaLISA SureFire Ultra reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining AlphaLISA SureFire Ultra quality.

1-plate-assay-protocol-AlphaLISA-Surefire-Ultra-Total-assay

Assay validation

Induction of Total HIF-2α in HEK293 cells

HEK293 cells were seeded in a 96-well plate (40,000 cells/well) in complete medium, and incubated overnight at 37°C, 5% CO₂. The cells were treated with increasing concentrations of CoCl₂ or Roxadustat for 18 hours.

After treatment, the cells were lysed with 200 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). HIF-2α and Cofilin Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 2,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, CoCl₂ and Roxadustat triggered a dose-dependent increase in the levels of Total HIF-2α while Total Cofilin remained unchanged.

Pharmacological Validation (activator) of HIF-2α

img-hek293-cells-treated-with-roxadustat-alsu-thif-a

Assay versatility

HIF-2α expression in various cell lines

Adherent cells were seeded at 40,000 cells/well in a 96-well culture plate in complete medium and incubated overnight at 37°C, 5% CO₂. Cells were treated with CoCl₂ for 4 hours, then washed with HBSS and lysed with 100 µL of lysis buffer.

HIF-2α total levels were evaluated by AlphaLISA SureFire Ultra. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

Versatility of HIF-2α Total assay in various cell lines

Assay sensitivity

Assay sensitivity - cell lysate

Cell lysate was prepared from HEK293 cells cultured to confluence a T175 flask and stimulated with 250 µM CoCl₂ for 18 hours. Cells were lysed with Lysis Buffer for 10 minutes at RT with shaking.

Lysate was serially diluted in Lysis Buffer and HIF-2α Total levels were evaluated by AlphaLISA SureFire Ultra. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

Approximate number of cells per datapoint is indicated. The dotted line represents assay background. The assay can detect HIF-2α Total down to 500 cells/datapoint.

Specifications

Other specifications

Application	Cell Signaling
Automation Compatible	Yes
Brand	AlphaLISA SureFire Ultra
Detection Modality	Alpha
Product Group	Kit
Protocol Time	2h at RT
Sample Volume	30 µL
Shipping Conditions	Shipped in Blue Ice
Target	HIF2α
Target Class	Phosphoproteins
Target Species	Human
Technology	Alpha
Therapeutic Area	Inflammation
Unit Size	100 Assay Points